AERIE PHARMACEUTICALS INC Annual Return On Equity in % from 2014 to 2021

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2014 to 2021.
  • Aerie Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2022 was 32.6 %, a 95.2% decline year-over-year.
  • Aerie Pharmaceuticals Inc annual Return On Equity for 2021 was 213 %.
  • Aerie Pharmaceuticals Inc annual Return On Equity for 2020 was -243 %, a 121% decline from 2019.
  • Aerie Pharmaceuticals Inc annual Return On Equity for 2019 was -110 %, a 9.93% decline from 2018.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2021 213 +457 Jan 1, 2021 Dec 31, 2021
2020 -243 -133 -121% Jan 1, 2020 Dec 31, 2020
2019 -110 -9.96 -9.93% Jan 1, 2019 Dec 31, 2019
2018 -100 +2.61 +2.54% Jan 1, 2018 Dec 31, 2018
2017 -103 +80.4 +43.9% Jan 1, 2017 Dec 31, 2017
2016 -183 +39.1 +17.6% Jan 1, 2016 Dec 31, 2016
2015 -222 -119 -114% Jan 1, 2015 Dec 31, 2015
2014 -104 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.